CALGARY, AB / ACCESSWIRE / August 22, 2024 / ASIA GREEN BIOTECHNOLOGY CORP. (CSE: ASIA) ("Asia Green" or the "Company") is pleased to announce that it has entered into a non-binding letter of intent ("LOI")...
CALGARY, AB / ACCESSWIRE / August 21, 2024 / Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announced today that it has elected to the terminate the previously announced agreement dated...
CALGARY, AB / ACCESSWIRE / November 9, 2021 / Asia Green Biotechnology Corp. ("Asia Green" or the "Company") (CSE:ASIA) announced today that it has secured and completed an agreement with a director of...
CALGARY, AB / ACCESSWIRE / August 10, 2021 / Asia Green Biotechnology Corp. ("AGB" or the "Company") (CSE:ASIA) is pleased to announce that it has entered a new agreement with Pathway Rx Inc. ("Pathway...
CALGARY, AB / ACCESSWIRE / August 5, 2021 / Asia Green Biotechnology Corp. ("Asia Green" or the "Company") (CSE:ASIA) announced today that it has secured an agreement with a director of the Company to...
CALGARY, AB / ACCESSWIRE / May 10, 2021 / Asia Green Biotechnology Corp. ("Asia Green" or the "Company") (CSE:ASIA) announced today that InPlanta Biotechnology Ltd. ("InPlanta"), the Company's partner...
CALGARY, AB / ACCESSWIRE / March 8, 2021 / Asia Green Biotechnology Corp. ("AGB" or the "Company") (CSE:ASIA) announced today that the Company continues to successfully implement its business plan in SE...
CALGARY, AB / ACCESSWIRE / February 9, 2021 / Asia Green Biotechnology Corp. ("AGB" or the "Company") (CSE:ASIA) is pleased to announce that it has entered an agreement with Pathway Rx Inc. ("Pathway Rx")...